NPC(SH:600713) Xin Lang Cai Jing·2025-10-09 07:56Core Viewpoint - Nanjing Pharmaceutical announced that its convertible bonds will start converting into shares from July 1, 2025, with a total conversion amount of 66,000 yuan and 12,875 shares formed by conversion as of September 30, 2025, representing 0.00098% of the company's total issued shares before conversion [1] Summary by Sections - Convertible Bonds Conversion Schedule - The conversion of Nanjing Pharmaceutical's convertible bonds will commence on July 1, 2025, and end on September 30, 2025 [1] - Conversion Amount and Shares - As of September 30, 2025, the cumulative conversion amount is 66,000 yuan, resulting in 12,875 shares, which is 0.00098% of the total shares issued before the conversion [1] - Remaining Convertible Bonds - As of September 30, 2025, the unconverted amount of Nanjing Pharmaceutical's convertible bonds is 1.081 billion yuan, accounting for 99.9939% of the total issuance [1]